In Vitro Diagnostics (IVD)

At SamikDx, we recognize the transformative power of in vitro diagnostics (IVD) in modern healthcare. IVD plays a pivotal role in enabling precise, timely, and personalized patient care through the analysis of biological samples outside the human body. These tests provide critical information that healthcare providers rely on for diagnosing diseases, monitoring treatment effectiveness, and guiding patient management decisions. IVD plays a critical role in public health programs, from screening for infectious diseases to monitoring population health trends.

It is our intention to develop and manufacture diagnostic kits using ELISA and Lateral Flow Assay (LFA) to combat infectious diseases, for detection of pathogens, toxins, hormones, antibiotics, micro nutrients, vitamins & other biological samples viz. cancer, fertility, and genetic diseases, such as sickle cell anemia, etc. We strongly believe that this will provide a great service to humanity by providing affordable testing kits.

Pipeline Products

At SamikDx, we are dedicated to pushing the boundaries of in vitro diagnostics (IVD) through our robust pipeline of innovative products. Our ongoing research and development efforts focus on addressing unmet clinical needs and advancing diagnostic capabilities across various medical fields. Here's a glimpse into our exciting pipeline:

1. Point-of-Care (POC) Testing Platforms: Our team is innovating compact and user-friendly POC testing platforms that deliver rapid and reliable results at the patient's bedside or in remote settings. These platforms target infectious diseases, cardiac markers, hormones, infertility, dementia, and other critical biomarkers to support timely clinical decision-making. Tests performed at or near the patient for rapid results (e.g. pregnancy tests, flu tests).

2. Microfluidic Devices: Leveraging microfluidic technology, we are developing miniature diagnostic devices that integrate sample preparation, amplification, and detection processes into a single platform. These devices promise to streamline workflows, reduce sample volumes, and enhance diagnostic accuracy for a wide range of applications.

3. Biomarker Panels: Our research includes the discovery and validation of novel biomarker panels for early disease detection, prognostic assessment, and therapeutic monitoring. These panels combine multiple analytes to provide comprehensive diagnostic insights and improve patient outcomes.

4. Digital Diagnostic Solutions: We are exploring digital diagnostic solutions that leverage artificial intelligence (AI) and machine learning algorithms to analyze diagnostic tests results and assist clinician in making more accurate diagnostic interpretations. These solutions aim to enhance diagnostic efficiency and facilitate remote consultation.

Our commitment to innovation and scientific excellence drives our pipeline development. Each product is rigorously evaluated through clinical studies to ensure regulatory compliance and meet the highest standards of performance and reliability. Stay tuned as we continue to advance these pipeline products towards commercialization, delivering impactful solutions that transform healthcare diagnostics and improve patient care worldwide.